Literature DB >> 9025863

Nonteratoid medulloepithelioma of the retina with electron microscopic and immunohistochemical characterization.

M Vadmal1, E Kahn, P Finger, S Teichberg.   

Abstract

Medulloepitheliomas are rare intraocular tumors, predominant in children, and originate mainly from undifferentiated nonpigmented epithelium of the ciliary body. These tumors rarely involve the optic nerve or the retina. They are classified as nonteratoid and teratoid types; the latter contains heterologous tissues. The teratoid variant of medulloepitheliomas involving the optic nerve or the retina is reported in four patients only. We describe the first case of a benign nonteratoid medulloepithelioma of the retina in a 3 1/2-year-old girl with immunohistochemical and electron microscopic characterization.

Entities:  

Mesh:

Year:  1996        PMID: 9025863

Source DB:  PubMed          Journal:  Pediatr Pathol Lab Med        ISSN: 1077-1042


  4 in total

1.  Growth of congenital malignant teratoid medulloepithelioma of the ciliary body: a case study.

Authors:  Alfonso Cerase; Sonia De Francesco; Alberto Citterio; Theodora Hadjistilianou; Alex Malandrini; Domenico Mastrangelo; Paolo Toti; Carlo Venturi
Journal:  J Neurooncol       Date:  2009-08-08       Impact factor: 4.130

2.  Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy.

Authors:  Sukriti Mohan; William Steven Gange; Jonathan Kim; Maria Elena Sibug Saber
Journal:  Case Rep Ophthalmol       Date:  2022-03-17

3.  Successful treatment of metastatic congenital intraocular medulloepithelioma with neoadjuvant chemotherapy, enucleation and superficial parotidectomy.

Authors:  Justin B Hellman; George J Harocopos; Lily Koo Lin
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-21

Review 4.  Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management.

Authors:  Sameeksha H Tadepalli; Carol L Shields; Jerry A Shields; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.